Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms
US8791242B2 · kind B2 · utility
4Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2011 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Nov 9, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/202
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a canine TSLP protein and a nucleic acid that encodes that protein. Peptide fragments of the protein that comprise specific epitopes of the canine TSLP protein are also disclosed. The canine TSLP protein and related peptide fragments may be used as an antigen for immunological assays, as well as for vaccines that induce anti-TSLP antibodies. The present invention further discloses methods of making and using the canine TSLP gene, the canine TSLP protein, and the related peptide fragments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.